TATYANA ERDMANN: Open Payments
NPI 1073659611 · DEWEY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 51 payments from 18 companies in 2025. Trend: 2023 $1,265 · 2024 $1,154 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $300 |
| AstraZeneca Pharmaceuticals LP | 7 | $241 |
| ABBVIE INC. | 4 | $93 |
| GlaxoSmithKline, LLC. | 4 | $81 |
| Aimmune Therapeutics, Inc. | 3 | $71 |
| CVRx, Inc. | 2 | $62 |
| Exact Sciences Corporation | 2 | $53 |
| Lilly USA, LLC | 2 | $43 |
| ZOLL Respicardia, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $38 |
Products named: AIRSUPRA, KRYSTEXXA, TRELEGY ELLIPTA, ZENPEP, EVENITY, Barostim Neo System, UBRELVY, remede System.
Industry payments across AZ — which companies pay providers there.
